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The neuromuscular junction has been the subject of several review articles and lectures in the last few years (Fatt, 1954; del Castillo and Katz, 1956; Katz, 1958 Katz, , 1962 Miledi, 1961) , and reference to these and to the literature shows that transmission across this junction is not the result of one function but of many.
It appears that neuromuscular transmission is a multistage operation and that failure at any one stage can mean complete failure of the whole system. It is equally clear that there are many modifying influences operating on the various stages of the transmission process, sometimes with complementary effects on the end result, sometimes with opposing effects. It follows, therefore, that when investigating a failure of neuromuscular transmission, whether occurring as a result of disease or the application of drugs or even under the more normal circumstances of excessive use, due regard must be paid to possible changes at all of these stages of transmission. A point of some importance in this respect is that an apparent failure at one stage may in fact be due to a real failure in the preceding stage; this factor will be referred to again when the mechanism of release of acetylcholine has been described.
In any discussion of the physiology of the neuromuscular junction, some attention must be paid to the anatomy of the region. There are many examples in the literature of the histological picture of the junction based on studies using nerve stains such as methylene blue or of methods involving the activity of acetylcholinesterase. For the purposes of this article, however, attention will be focused on "the structure of the junctional region as seen with the aid of the electron microscope, with special reference to the human palmaris longus muscle as described by de Harven and Coers (1959) . Drawings have been made based on two of the photographs from this paper and these are shown in figures 1 and 2. 510
In the first figure, the plane of the section has cut across the three main histological elements involved in neuromuscular transmission. They are: the motor nerve ending, the specialized region of sarcoplasm underlying it, and the contractile element of the muscle fibre. A more detailed picture of the contact region between nerve and muscle fibre is shown in figure 2, a drawing of an area similar to that indicated by the rectangle in figure 1. In these two figures, points of major interest with regard to the physiology of transmission are (a) the folding of the sarcoplasmic membrane immediately beneath the nerve fibre, (b) the very narrow but definite gap in between nerve and muscle, which the chemical transmitter must traverse, and (c) the presence of vesicular objects in large numbers in the motor nerve endings. With these histological features in mind we can attempt some description of the physiological mechanisms associated with them.
The work of Dale and his colleagues Brown et al., 1936) provided clear evidence that acetylcholine was associated with transmission of activity from nerve to muscle. Their results may be summarized thus:
(1) Acetylcholine is found in venous outflow from a muscle when it is stimulated via its motor nerve.
(2) Acetylcholine is not found when the sensory nerve fibres to the muscle are stimulated, nor when the stimulus is applied directly to a previous denervated muscle.
(3) Injection of a small quantity of acetylcholine into an artery close to the muscle produces a brief tetanus accompanied by a burst of electrical activity (action potentials) in the muscle, thus mimicking the action of motor nerve stimulation.
(4) After the acetylcholinesterase has been put out of action with eserine, a single shock applied to the motor nerve produces a contraction in the muscle which is stronger and of a longer duration than normal and this contraction is supported by repetitive electrical activity in the muscle. In view of these results and in the light of more recent studies using micro-electrodes which have made it possible to investigate the finer detail of the microphysiology of the neuromuscular junction, the main stages in transmission have been set out as a diagram shown in figure 3 . Functionally, as well as histologically, the neuromuscular junction is divided into two parts by the synaptic cleft; one part relates to activity in the motor nerve endings, the other to activity in the muscle fibre. In the account of neuromuscular transmission which follows, the process will be considered to begin with the transmission of an action potential along the fine terminal branches of the motor nerve and to end with the initiation of an action potential in the muscle fibre. In thus limiting the scope of this article, it is perhaps as well to point out that successful propagation of an action potential along the muscle fibre, and operation of the link mechanism with the contractile system inside the fibre, are necessary stages in the production of the normal mechanical response of muscle to motor nerve activity. Failure of either of these two stages may produce a block equally as effective as that resulting from, say, the giving of curare. At the other end of the junction, while the normal mode of transmission of activity along nerve fibres will not be discussed, some comments will be made on changes in function of the fine nerve terminals which may have a part to play in neuromuscular fatigue and failure during periods of excessive use.
ACETYLCHOLINE SYNTHESIS
On the basis of available evidence, it seems probable that the major part of acetylcholine synthesis occurs in the motor nerve endings by the transfer of acetyl groups from coenzyme-A to choline under the influence of the enzyme choline acetylase. The substrate for this reaction, choline, is present in adequate quantities in normal plasma. Since it cannot penetrate the membrane of the nerve axon, it seems possible that in the nerve endings there exists some mechanism for transporting choline from an extra-to an intracellular position in contact with acetylating enzyme. Also present in the motor nerve endings is the enzyme acetylcholinesterase and the store of acetylcholine must therefore be protected in some way from the destructive action of this enzyme. A form of chemical binding of the acetylcholine is a possibility, but it is one which is made unlikely by the relatively simple physical procedures which are required to extract it from the nerve endings. Alternatively, acetylcholine may be stored inside some subcellular membrane through which the esterase cannot move. The vesicles observed at motor nerve endings, as well as at other synaptic regions, have been thought of as possible locations for stored acetylcholine. While conclusive proof that these vesicles do contain acetylcholine is still lacking, it is a theory which fits in remarkably well with electrophysiological observations of acetylcholine release.
Failure of neuromuscular transmission due to inadequate synthesis of acetylcholine is a possibility which can be considered at this stage. While a defect in any of the metabolic processes leading to and supporting the acetylation reaction may result in a failure of acetylcholine production, a more specific cause of failure has been investigated by Schueler (1955) and Macintosh (1959) . These workers have suggested that the hemicholinium compounds compete with choline for the transport system thought to exist at synaptic regions and so prevent choline from entering the nerve ending and reaching the site at which acetylation takes place. While such inhibition undoubtedly occurs in sympathetic ganglia, it is still not clear whether or not it plays any part in the neuromuscular blocking action of the hemicholiniums. To some extent the picture here is obscured by the curare-like activity of these compounds (Thies and Brooks, 1961) . Furthermore, neuromuscular block due to deficient acetylcholine synthesis is only likely to show up when the local stores of the transmitter have been reduced by a prolonged period of nerve activity, which in itself, in untreated nerve endings, reduces the quantity of transmitter released (Brooks and Thies, 1962) .
ACETYLCHOLINE RELEASE
It now seems fairly clear that acetylcholine release takes place in a discontinuous manner, the transmitter leaving the nerve not molecule by molecule but as groups or packets of molecules or quanta, each quantum containing several hundred molecules (del Castillo and Katz, 1954a, b; Martin, 1955) . The discharge of one quantum from the nerve ending and its arrival at the acetylcholine receptor is signalled by a small (0.5 mV) and transient depolarization of the postjunctional muscle membrane. Moreover, in the absence of any motor nerve activity, these small potential changes may be observed at the junction, occurring at a rate which is random but which may be altered by many factors. Because of their small size and their similarity to endplate potentials, the small random potentials have been termed "miniature endplate potentials", or "minepps" for short (Fatt and Katz, 1952) and each one signals the spontaneous release of a single acetylcholine quantum. Among the many factors affecting the frequency of occurrence of these spontaneous minepps is one which has a direct bearing of the link in between motor nerve activity and acetylcholine release. This is the membrane potential of the motor nerve endings.
It has been shown that a reduction of this membrane potential, produced either by electrical means or by an increase in the potassium concentration in the surrounding medium, increases the frequency of the minepps (del Castillo and Katz, 1954b) . A quantitative relation between depolarization and minepp frequency has been shown in the rat (Liley, 1956 ) and in the frog (Roberts, unpublished work). In both species a depolarization of 30 mV increases the frequency by a factor of 100. Now during the invasion of the motor nerve endings by an action potential travelling down the axon, there will be a rapid and profound depolarization of the nerve membrane. The amplitude of this membrane potential change is about 100 mV and its duration about 1 millisecond. During this short period of time there is an increase in the rate of release of acetylcholine so that several hundred quanta may be released, more or less simultaneously, by one nerve action potential. It is this spurt in acetylcholine release which is able, under normal circumstances, to produce a sufficient concentration of the transmitter at the postjunctional receptor sites to initiate the permeability and potential changes which precede muscular contraction.
While it is clear that there is a connection between the nerve membrane potential and acetylcholine release, the nature of the link between them is unknown. Nor is it clear whether the spontaneous release of acetylcholine takes place along the same channel as the nerve-induced release, since under certain experimental conditions the two modes of release may be altered in opposite ways. Thus, after a period of nerve stimulation at 2-5/second for 7-10 minutes there was found to be a reduction in the number of quanta released per nerve impulse, but an increase in the spontaneous rate of release (del Castillo and Katz, 1954a) . It is known, however, that the divalent cations of magnesium and calcium play some part in the connection between potential change and release (del Castillo and Katz, 1954a; Liley, 1956; del Castillo and Engbaek, 1954; Jenkinson, 1957) . In the presence of a reduced calcium and an increased magnesium concentration in the fluid surrounding the nerve ending, there is a reduced quantal level of release. The amount of reduction in release is proportional to the degree by which the concentrations of these two ions vary from the normal. It may be sufficient to reduce transmitter output level below the minimum for neuromuscular transmission to occur, or, if more severe, some or all of the nerve action potentials may fail to release any acetylcholine at all.
It is under these conditions of reduced quantal output that the random nature of acetylcholine release becomes most apparent (cf. random spontaneous release). By a judicious adjustment of the Ca/Mg ratio it is possible to reduce the output level to a few quanta per nerve impulse. Electrical recordings of the endplate responses to a series of nerve stimulations now show wide fluctuations in amplitude and these vary in a stepwise manner, corresponding to the number of quanta released. The probability of release of acetylcholine quanta appears to vary above and below a mean value which can be altered by environmental conditions. Not only does it depend on the Ca/Mg ratio, but it is reduced by a period of rapid nerve stimulation so that a neuromuscular block very similar in its mechanism to that produced by Ca/Mg adjustment may arise as a result of prolonged nerve activity. Part at least of this effect may be due to a progressive failure of the nerve action potential to invade some of the finer nerve terminals and so trigger off acetylcholine release (Miledi, 1961) . Other contributory factors may be concerned with the intracellular and membranal events immediately preceding acetylcholine release. A variation in the mean quantal level in the opposite direction may be observed when two nerve stimuli are applied with a very short interval of time in between. Under such conditions it is found that the second stimulus releases more acetylcholine quanta than the first and, moreover, the probability of release in response to the second stimulus is increased by the first, even though this itself does net succeed in releasing any acetylcholine. It seems that the invasion of the nerve terminals by an action potential, as well as releasing some acetylcholine, produces a temporary disturbance of conditions which favour future release. In a somewhat similar manner the quantal release level in response to a single nerve stimulus is greater after a period of rapid nerve activity than before it, i.e. there is posttetanic facilitation of acetylcholine release.
At a more clinical level, the neuromuscular block obtained with Ca/Mg adjustment, or prolonged nerve activity, may have a direct bearing on myasthenia gravis. It has been shown (Dahlback et al., 1961 ) that in muscle from myasthenic patients the release of acetylcholine in response to nerve activity is at a very reduced quantal level and there is some evidence that injection of calcium improves neuromuscular performance in the myasthenic subject (George and Haan, 1962) . These authors in fact attribute their success with calcium to its action on acetylcholinesterase, but in view of the widespread role of calcium in nerve and muscle activity, a determination of the effect of calcium on quantal output in myasthenia would seem to be the next logical step.
THE RECEPTION OF ACETYLCHOLINE
Once the acetylcholine has been released, all further events in the transmission process are a function of the postjunctional apparatus, and factors modifying these events will operate postjunctionally. In the simplest of terms, acetylcholine reception depends on and results in certain conditions.
(a) The presence of a modified part of the muscle membrane immediately underlying the nerve ending. This modification takes the form of the provision of a large number of receptor sites on the outside face of the chemical structure of the muscle membrane to which acetylcholine can attach itself.
(fc) The ionic permeability of the muscle membrane must depend in some way on the acetylcholine/receptor link so that if the link is formed, the permeability is very many times greater than normal, i.e. ions are able to move through more easily.
(c) While the duration of acetylcholine action will be limited by its diffusion away from the receptor sites, a quicker means of limitation is provided by the destructive action of the enzyme, acetylcholinesterase.
As a result of these conditions, the arrival of acetylcholine at the postjunctional receptor sites, either by natural release from the nerve ending or by experimental application to the preparation, will be signalled by a transient reduction of the membrane potential of the muscle fibre. This potential change is recorded maximally only at the postjunction or endplate region of the muscle fibre (hence the term "endplate potential") and while signs of this electricity activity can be detected at points a few millimetres away from the endplate, their amplitude and shape indicate that this is due to the membrane acting as a rather poor electrical conductor, and not to any true spread of acetylcholine effect along the fibre. The endplate potential itself has a characteristic time course (rapid onset, slow decay) which reflects the manner in which it arises.
The initial rapid phase occurs during the time in which the transmitter is active at the receptor sites. Under resting conditions, i.e. no acetylcholine present, the membrane potential is determined mainly by the difference in potassium concentration inside and outside the fibre, since the muscle membrane is relatively more permeable to this ion than to the others which are present. During the phase of transmitter action, when the acetylcholine/receptor link is operative, the membrane permeability to all the ions increases. Under these new circumstances, the membrane potential is determined by the intra-and extra-cellular concentration of sodium, potassium and chloride ions, which would support a potential of some 10-20 mV, the inside of the fibre still being negative to the outside. During this time, therefore, the membrane potential will start to swing from its resting value of about 93 mV to the new equilibrium at 10-20 mV and the rate at which this potential change occurs (in millivolts/millisecond) depends on the number of receptor sites activated by acetylcholine. The greater the number of active sites, the more will the permeability/unit area increase and the electrical resistance decrease. As a result, the time constant of the membrane (equal to the product of the electrical capacity and resistance associated with it) is decreased, and therefore the membrane potential can change more rapidly towards the new equilibrium value. It does not in fact ever reach this value since under normal conditions an action potential is generated in the adjacent membrane and the larger potential changes of the active membrane overshadow the smaller endplate potential. Moreover, a time limit to the transmitter action is set by the destructive effect of the acetylcholinesterase. The result is that, as soon as acetylcholine hydrolysis is complete, the postjunctional membrane permeability and time constant return to normal and the membrane potential commences its return to the normal level at a very much slower rate.
It is in this sort of context that the actions of curare* and neostigmine can be described. The curare molecule, while very much larger than that of acetylcholine, seems to be able to form some sort of bond with the acetylcholine receptor sites on the muscle membrane, so that when both molecular species are present the number of receptor sites * The term "curare" is preserved in this section because (a) it is a term familiar in physiological circles and (b) crude curare was used in the early experiments on neuromuscular transmission. What is written of "curare" will apply to any "antidepolarizing drug".-Editor.
occupied by each is determined by the relative proportions of the two competitors. The blocking action of curare arises because its linkage with a receptor site does not initiate the permeability changes that occur with acetylcholine. When curare is present, therefore, the activity of acetylcholine is restricted with a resultant smaller change in endplate potential. Neuromuscular block occurs when the potential change does not reach the threshold value within the allotted time. It also follows that the block produced by any given concentration of curare may be overcome, if the amount of acetylcholine released is increased, as by the second of two closely spaced nerve stimuli or after a brief tetanus. The greater numbers of acetylcholine molecules can now compete on better terms with the curare and so produce an adequate potential change at the endplate. Alternatively, what acetylcholine is released may be permitted to act for a longer time by blocking the acetylcholinesterase with neostigmine, so that the potential change may continue for longer than the normal time and so be more likely to exceed the threshold for action potential initiation. Under normal circumstances, when no curare is present, the action of neostigmine in prolonging the transmitter action results in the generation of more than one action potential. There is, however, another aspect of neostigmine action which has some practical application. Its anticholinesterase activity is well seen in a concentration of 10"° w/v; if this be increased to 10~s, the neostigmine begins to act like curare and to block the action of acetylcholine. This effect is independent of any block which may be produced by persistence of acetylcholine at the endplate due to a reduction in the normal cholinesterase action. It seems that neostigmine is sufficiently like acetylcholine to compete with it, not only for the cholinesterase receptor groups but also for the receptors on the postjunctional membrane. This, of course, raises at once the question of a possible connection between cholinesterase and receptor sites; just how closely are they related in the postjunctional region?
From this somewhat superficial survey of the action of acetylcholine at the neuromuscular junction certain questions naturally arise.
(1) What is it that determines the distribution of acetylcholine receptors?
(2) What is the nature of the link between acetylcholine/receptor combination and change in membrane permeability? (3) Why is it that some substances are excitatory (i.e. they can produce depolarization) while others merely block the receptor sites, and how is it that a substance which initially excites can secondarily block neuromuscular transmission?
These three questions will now be considered.
ACETYLCHOLINE RECEPTORS AND ACETYLCHOLINESTERASE
Certain information is now available concerning the distribution on the muscle fibre membrane of acetylcholine receptors. They exist in the heaviest concentration immediately underneath the nerve terminals-probably in the folded part of the membrane shown in figure 2-and in this situation they are very properly called "junctional" receptors. However, while in mammalian muscle the endplate is some 20-30 microns in diameter, the acetylcholine sensitive region of the muscle fibre extends over a length of about 1 mm. It is clear, therefore, that there are many "extrajunctional" receptors situated on the muscle membrane immediately around the endplate. The reasons for their existence and their possible function are not known, but it appears, from studies in which the sensitivity of the membrane to acetylcholine released from a micro-electrode has been tested, that the density of these extrajunctional receptors rapidly decreases as the distance from the endplate increases. As a result, the sensitivity to acetylcholine of the muscle membrane 1 mm away from the endplate is 100,000 times less than that of the junctional region itself.
No account of acetylcholine receptors would be complete without some reference to three sets of circumstances in which their distribution does not follow the normal pattern as outlined above. In embryonic skeletal muscle, before innervation has taken place, in skeletal muscle after denervation and before subsequent re-innervation, and in botulinum poisoned muscle, acetylcholine receptors are to be found all along the surface of the muscle fibre membrane. After section of the motor nerve, the acetylcholine-sensitive region appears to spread out from the endplate until it involves the whole fibre. Moreover, the density of distribution of receptors is such that, while the endplate is still the most sensitive part, the difference between it and the rest of the fibre is much less than normal. If the experiment is allowed to continue until nerve regeneration occurs and the muscle is re-innervated, the sensitive region is found to shrink in size to the normal 1 mm length of muscle fibre. In embryonic skeletal muscle the pattern of events is very similar to that in adult muscle recovering from denervation. The embryonic muscle starts off with acetylcholine receptors spread over the whole of its surface. When innervation of the muscle is established its sensitive zone contracts until only the endplate region is sensitive. In the case of botulinum poisoning, a functional denervation is brought about when the toxin interferes with the synthesis or release of acetylcholine and once again there is an increase in the sensitive area of the muscle fibre.
As far as can be seen, the one common factor in these three conditions is the absence of acetylcholine and it is tempting to come to the conclusion that the release of acetylcholine from nerve endings in some way inhibits the existence of receptors except at the junction itself.
There is, however, some evidence against such a simple explanation. It has been shown (Katz and Miledi, 1961 ) that if a non-innervated part of a muscle fibre be cut across and so detached from the rest of the fibre, on recovery from the operation this separated section of muscle fibre will be found to have a greater sensitivity to acetylcholine than normal. Moreover, Miledi (1960) has shown that if a denervated muscle is kept in contact with acetylcholine for several days, no change is observed in the distribution of acetylcholine receptors. In other words, the mere presence of acetylcholine does not, by itself, reduce the sensitive area of the membrane to that immediately surrounding the endplate. Also, during the process of re-innervation after denervation, the sensitive area is reduced to the normal size before the nerve fibres are fully able to conduct impulses to the junction. It seems, therefore, that the nerve fibre, as well as influencing the muscle by way of acetylcholine release, has other actions on the muscle which, perhaps, reduce the rate at which receptors are produced all along the fibre and so leave an effective concentration of receptors only at the endplate region. These actions may be similar to the trophic effect of nerves on fast and slow muscles in the cat (Buller et al., 1960) .
It is useful at this stage to consider the distribution of the cholinesterase groups in the muscle fibre membrane since this also varies with the state of innervation of the muscle. Histochemical techniques have shown that cholinesterase is present at the junctional region of muscle fibres (Couteaux, 1955) , but by using a fast-acting anticholinesterase drug, edrophonium, Miledi (1962) has demonstrated that the cholinesterase is distributed over the same length of membrane as the true junctional acetylcholine receptors, while the extrajunctional receptors have no cholinesterase associated with them. After denervation, there is a loss of cholinesterase from the junction which can be demonstrated both histochemically and physiologically by the effect of edrophonium on the potential produced by externally applied acetylcholine. The additional acetylcholine receptors which appear along the length of the muscle fibre are not accompanied by any cholinesterase; nor does cholinesterase appear in a transected, non-innervated portion of a fibre, although this does become sensitive to acetylcholine. On the other hand, it is possible to induce a functional neuromuscular junction into a part of a muscle fibre not normally containing any endplates by removing a nerve from its normal position on the muscle and suturing its cut end to another part of the fibre. On regeneration of the motor nerve, functional contact is established with the muscle, stimulation of the nerve causes contraction of the muscle and cholinesterase is found to be present at the new innervation site. It is clear that there is some connection between a functioning neuromuscular junction and the presence of cholinesterase in the muscle membrane immediately underneath the nerve ending, but the nature of the link and its possible relation to the development of acetylcholine receptors is unknown.
ACETYLCHOLINE AND PERMEABILITY

CHANGES
As regards the link between acetylcholine reception and changes in membrane permeability and the basic differences in the action of excitatory and inhibitory substances, there is as yet no clear picture. There are, however, a number of theories put forward in connection with this phase of neuromuscular transmission and the main facts which they have to account for are as follows.
Substances which act on the postjunctional membrane may be divided into two categories, depending on whether they depolarize the mem-brane or not. Thus in one group there are agents like acetylcholine which lower the membrane potential by altering the ion permeability of the membrane and are basically excitatory in character. In the other group are substances like curare which combine with the same receptors as acetylcholine, but do not operate the link with the permeability change mechanism and so are able to act as blocking agents. The position is somewhat more complicated than this, however, because the depolarizing agents, if allowed to persist in the region of the endplate, can act as blocking agents in a way similar to the former group. It seems that their initial action is to depolarize the membrane, and so first excite and then block by preventing any further potential change-depolarization block. This effect is a transient one which soon wears off and is followed by a second type of action in which the acetylcholine receptors remain occupied, and therefore blocked to the action of more acetylcholine, but the link with the membrane permeability is not operative any longer. This double action gave rise to the suggestion that the acetylcholine/receptor complex formation takes place in two stages, the first one being inactive and the second active or depolarizing in nature. Under such circumstances the excitatory activity of the agent would depend on the rate at which the second and active form was produced, which in turn would depend on the rate of dissociation of the first form and the rate of destruction of the second form by acetylcholinesterase.
So far in this discussion it has been assumed that the difference between depolarizing and antidepolarizing agents is due to differences in their chemical structures. On the lock-and-key analogy, acetylcholine is a key which not only fits the lock but which can also be turned to operate the permeability change which produces the depolarization. On the same basis, curare fits the lock but not well enough to alter the permeability. In more precise terms, both ends of the acetylcholine molecule are used to form the link with the receptor on the muscle membrane, the nature of the chemical bond being different at the two ends. The curare molecule, much larger than acetylcholine, can form only one kind of these bonds and so has no effect on the membrane permeability. It does, however, occupy some of the receptor points which would otherwise be available to acetylcholine and to this extent it reduces the action of the depolarizing agent. Given a chemical structure which can produce a depolarizing effect, the magnitude of action of any such agent will depend on the number of receptors which it can occupy in competition with any antidepolarizing agent which is present.
Recently, attention has been drawn to an alternative possible explanation of the differences between excitatory and blocking agents (Paton, 1961) . While it has been assumed that an acetylcholine molecule has a depolarizing effect as long as it is bound to a receptor, this is not necessarily so. Paton's theory of drug action is based on the possibility that a permeability change only occurs at the moment when the drug-receptor bond is formed but that no further action takes place until this bond is broken and a new one formed. In other words, it is the process of occupation of a receptor group which provides the trigger for the excitation mechanism, rather than the occupation itself. The magnitude of the excitation produced will thus depend on the rate at which receptors are occupied, and this will be a function not only of the drug itself but also of the number of available receptors, that is, receptors not occupied by an antagonist or by the excitatory drug. Once some of the receptors have been occupied by the drug, however, another factor becomes significant and has to be taken into account. This is the rate at which dissociation of the drug-receptor complex occurs. When this rate is high, receptors are rapidly freed from the drug and become available for further activity; if the rate is slow, then the number of receptors occupied will gradually build up and so reduce the rate at which drug-receptor bonds can be made. Thus, once the initial occupation of receptors by the drug has taken place, the magnitude and duration of further excitation effects will be determined by the rate at which the drug can dissociate from combination with receptors.
It follows from this that the response to the application of an excitatory drug will be waning in character, the maximal effect being produced initially when the rate of association of the drug and receptors is high but decreasing to a steady value when an equilibrium state is reached between association and dissociation. Furthermore, if the rate of dissociation is very slow, then the excitatory effect of the drug will be very transient in duration and will quickly give way to blocking action as all the receptor sites become occupied. In between these two extremes a drug may exhibit first a definite excitatory effect turning, if the application is maintained long enough, into a blocking effect. Thus the quality of action of a drug as well as the magnitude can be explained in terms of the dissociation rate constant, without discussing the precise nature of the bond in between drug and receptor or the mechanism underlying the change in permeability.
In order to explain such phenomena as desensitization and supersensitivity after denervation, Paton has extended his theory and suggested that the process of excitation involves the movement out from the muscle of potassium ions. After prolonged exposure to an excitatory drug, the intracellular store of potassium may be expected to be depleted and the transmission process could well fail on this account even though there were further receptors available. After denervation and degeneration of nerve fibres, there is no longer any resting discharge of the transmitter, and this might well lead to an increase in intracellular potassium and an increased excitatory effect when the junction is tested by external application of the transmitter agent. As Paton points out, these changes in sensitivity should be nonspecific, since the availability of receptors is not a critical factor. No matter what the excitatory agent or which receptors it uses, if there is a deficiency of intracellular potassium then occupation of these receptors will have a subnormal effect. Such is undoubtedly the case for smooth muscle, but owing to the high specificity of the motor endplate for excitatory agents the same cannot be said of striated muscle, although the development of sensitivity to adrenaline in the denervated rat diaphragm is perhaps a pointer in the same direction.
SUMMARY AND CONCLUSIONS
It will be obvious that in this brief review of the subject it has been impossible to do more than touch on its principal features. For instance, no attempt has been made to describe the experimental evidence in support of the quantal nature of acetylcholine release or of the action of acetylcholine and curare on membrane permeability and resistance. Nor has the rate theory of drug action been discussed at all adequately since it was felt that the bulk of the available evidence in its favour relates to smooth muscle and that its relation to neuromuscular transmission can only be assessed when more data is available about the reaction rates of the many processes involved.
From the practical point of view, the anaesthetist can regard skeletal neuromuscular transmission as a three-part process, involving three operations on acetylcholine, namely its release, its reception and its destruction. Each of the three parts is subject to individual variation and there is also some degree of interaction between them; clearly, no assessment of neuromuscular function is complete without reference to all the factors concerned. This applies in particular to the action of drugs, since a drug may have effects on more than one part of the system and, while under normal circumstances one of these may be dominant, alteration of conditions may enhance its other actions.
